The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants.
Berthou S, Aebersold DM, Schmidt LS, Stroka D, Heigl C, Streit B, Stalder D, Gruber G, Liang C, Howlett AR, Candinas D, Greiner RH, Lipson KE, Zimmer Y.
Berthou S, et al. Among authors: lipson ke.
Oncogene. 2004 Jul 8;23(31):5387-93. doi: 10.1038/sj.onc.1207691.
Oncogene. 2004.
PMID: 15064724